Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

29

Revenue 2017

Soliris

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Soliris was produced by Alexion.

HTA guidance from NICE, the SMC and the AWMSG

16 Apr 2021. NICE said clinical evidence shows Ultomiris is as effective and safe as Alexion's older PNH drug Soliris.

AZ raises full-year guidance after completing Alexion acquisition in Q2

AZ raises full-year guidance after completing Alexion acquisition in Q2 This includes the company’s complement component 5 (C5) inhibitors Soliris (eculizumab) and Ultomiris (ravulizumab), which are already available in the US and EU.

AZ’s PNH therapy Ultomiris wins EU backing to expand use for children

AZ’s PNH therapy Ultomiris wins EU backing to expand use for children who are clinically stable after treatment with Alexion’s older PNH drug Soliris (eculizumab). ... This includes the company’s complement component 5 (C5) inhibitors Soliris and Ultomiris, which are available in the US and EU.

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance

AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance This includes the company’s complement component 5 (C5) inhibitors Soliris (eculizumab) and Ultomiris (ravulizumab), which are already available in the US and EU.

UK’s Competition and Markets Authority to review AZ/Alexion merger

UK’s Competition and Markets Authority to review AZ/Alexion merger That includes the company’s complement component 5 (C5) inhibitors Soliris (eculizumab) and Ultomiris (ravulizumab), which are already available in the US and the EU. ... programmes. AZ projects that the acquisition will deliver double-digit average

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...